Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Bone Resorption, Osteoclastogenesis and Adalimumab (BROCA)

This study has been completed.
Information provided by (Responsible Party):
Artur de Brum-Fernandes, Université de Sherbrooke Identifier:
First received: December 23, 2008
Last updated: December 10, 2013
Last verified: December 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2011
  Primary Completion Date: September 2010 (Final data collection date for primary outcome measure)